Tag: Apoe4

In clinical trials for donanemab (brand name Kisunla), approximately 37% of participants experienced amyloid-related imaging abnormalities (ARIA), a key safety consideration for this Alzheimer's treatment. Understanding **what are the side effects of the drug donanemab?** is crucial for patients, caregivers, and clinicians considering this therapy.

Approximately 60% to 70% of Americans are infected with herpes simplex viruses. This high prevalence, along with evidence linking herpes to Alzheimer's pathology, has led scientists to investigate a crucial question: Does valacyclovir prevent dementia?.